Haleos Labs Ltd

NSE: HALEOSLABS · BSE: 540679 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹1,587.00
Market cap: ₹479.8 Cr
Revenue (annual): ₹333.8 Cr
Net profit (annual): ₹17.31 Cr
P/E (TTM): 30.4×Sector 47.4×
Promoter holding: 72.11%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 5 Other Announcement 4 Management Change 4 Financial Results 3 Dividend 2 Board Meeting Date 2 Promoter Reclassification 1 Credit Rating 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

22 May 2026 15:10 IST BSE

Credit Rating

Haleos Labs Credit Rating

Infomerics reaffirmed credit ratings for Haleos Labs and its subsidiary for ₹136.76 Crore in facilities. The outlook remains positive, reflecting stable operational performance.

Value: ₹136.8 Cr
Execution: Valid until May 20, 2027

Read the filing ↗